| Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study YP Mossé, MS Lim, SD Voss, K Wilner, K Ruffner, J Laliberte, D Rolland, ... The lancet oncology 14 (6), 472-480, 2013 | 777 | 2013 |
| Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy TM Tekautz, CE Fuller, S Blaney, M Fouladi, A Broniscer, TE Merchant, ... Journal of Clinical Oncology 23 (7), 1491-1499, 2005 | 467 | 2005 |
| Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma CH Pui, HH Mahmoud, JM Wiley, GM Woods, G Leverger, B Camitta, ... Journal of clinical oncology 19 (3), 697-704, 2001 | 424 | 2001 |
| Targeting ALK with crizotinib in pediatric anaplastic large cell lymphoma and inflammatory myofibroblastic tumor: a Children’s Oncology Group Study YP Mossé, SD Voss, MS Lim, D Rolland, CG Minard, E Fox, P Adamson, ... Journal of Clinical Oncology 35 (28), 3215, 2017 | 373 | 2017 |
| Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children’s Oncology Group SL Berg, SM Blaney, M Devidas, TA Lampkin, A Murgo, M Bernstein, ... J Clin Oncol 23 (15), 3376-82, 2005 | 370 | 2005 |
| Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop RJ Packer, JA Biegel, S Blaney, J Finlay, JR Geyer, R Heideman, J Hilden, ... Journal of pediatric hematology/oncology 24 (5), 337-342, 2002 | 278 | 2002 |
| Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study JLG Bender, PC Adamson, JM Reid, L Xu, S Baruchel, Y Shaked, ... Journal of clinical oncology 26 (3), 399-405, 2008 | 270 | 2008 |
| Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study MA Champagne, R Capdeville, M Krailo, W Qu, B Peng, M Rosamilia, ... Blood 104 (9), 2655-2660, 2004 | 260 | 2004 |
| Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC XN Li, Q Shu, JMF Su, L Perlaky, SM Blaney, CC Lau Molecular cancer therapeutics 4 (12), 1912-1922, 2005 | 257 | 2005 |
| Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study EA Raetz, MS Cairo, MJ Borowitz, SM Blaney, MD Krailo, TA Leil, JM Reid, ... Journal of Clinical Oncology 26 (22), 3756, 2008 | 250 | 2008 |
| A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study M Bond, ML Bernstein, A Pappo, KR Schultz, M Krailo, SM Blaney, ... Pediatric blood & cancer 50 (2), 254-258, 2008 | 237 | 2008 |
| Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines RJ Bernardi, AR Lowery, PA Thompson, SM Blaney, JL West Journal of neuro-oncology 86, 165-172, 2008 | 226 | 2008 |
| Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group S Malempati, B Weigel, AM Ingle, CH Ahern, JM Carroll, CT Roberts, ... Journal of Clinical Oncology 30 (3), 256, 2012 | 209 | 2012 |
| Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report IF Pollack, RI Jakacki, SM Blaney, ML Hancock, MW Kieran, P Phillips, ... Neuro-oncology 9 (2), 145-160, 2007 | 206 | 2007 |
| Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report M Fouladi, JR Park, CF Stewart, RJ Gilbertson, P Schaiquevich, J Sun, ... Journal of Clinical Oncology 28 (22), 3623, 2010 | 198 | 2010 |
| Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final … S Jeha, H Kantarjian, D Irwin, V Shen, S Shenoy, S Blaney, B Camitta, ... Leukemia 19 (1), 34-38, 2005 | 197 | 2005 |
| Bortezomib interactions with chemotherapy agents in acute leukemia in vitro TM Horton, A Gannavarapu, SM Blaney, DZ D’Argenio, SE Plon, SL Berg Cancer chemotherapy and pharmacology 58, 13-23, 2006 | 191 | 2006 |
| Nanoshell-mediated photothermal therapy improves survival in a murine glioma model ES Day, PA Thompson, L Zhang, NA Lewinski, N Ahmed, RA Drezek, ... Journal of neuro-oncology 104, 55-63, 2011 | 175 | 2011 |
| A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study TM Horton, D Pati, SE Plon, PA Thompson, LR Bomgaars, PC Adamson, ... Clinical cancer research 13 (5), 1516-1522, 2007 | 173 | 2007 |
| Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I … JLG Bender, A Lee, JM Reid, S Baruchel, T Roberts, SD Voss, B Wu, ... Journal of clinical oncology 31 (24), 3034, 2013 | 169 | 2013 |
Peter C. AdamsonChildren's Hospital of Philadelphia/UPennVerified email at email.chop.edu
